Quick Answer
Silexion Therapeutics Corp reported Common Stock Shares Outstanding of 3.13 billion shares for the year ending 2025.
- Silexion Therapeutics Corp showed an increase of +2,436.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Silexion Therapeutics Corp's annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Silexion Therapeutics Corp's Common Stock Shares Outstanding has grown by 3,119.4%.
- Historical annual values: Fiscal year 2025: 3.13 billion shares | Fiscal year 2024: 123.29 million shares | Fiscal year 2023: 97.12 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: